Cite

HARVARD Citation

    Abdulrazaq, A. et al. (2022). Minimal Manifestations With Eculizumab Therapy in a Patient With Refractory Generalized Seropositive Myasthenia Gravis. Journal of clinical neuromuscular disease. 23 (3), p. . [Online]. 
  
Back to record